Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTmt Investments Regulatory News (TMT)

Share Price Information for Tmt Investments (TMT)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.09 (3.66%)
Bid:
2.50
Ask:
2.60
Spread: 0.10 (4.00%)
Market Cap: $76.36m
TMT Live PriceLast checked at - London Stock Exchange

Intraday Tmt Investments Share Chart

Statement re Portfolio Revaluations

30 May 2018 07:00

RNS Number : 6014P
TMT Investments PLC
30 May 2018
 

30 May 2018

 

TMT INVESTMENTS PLC

("TMT" or the "Company")

 

Portfolio company revaluations and first "unicorn"

 

TMT Investments PLC (AIM: TMT.L), the venture capital company investing in high-growth technology companies across a number of core specialist sectors, is pleased to announce the following revaluations of the Company's core portfolio investments.

 

These developments collectively have generated an estimated increase of approximately US$12.82 million in the Company's net asset value ("NAV"), equivalent to approximately 43.9 cents per share (before adjustments for the Company's ongoing operating expenses, bonus provisions, insignificant revaluations, potential future impairments, and similar items). This represents an uplift in the Company's NAV of 18.1% from the previously stated figure of US$2.43 per share as at 31 December 2017.

 

Taxify

Taxify, a leading international ride-hailing company (www.taxify.eu), has announced that it has completed a US$175 million funding round led by global automotive leader Daimler AG. European venture capital fund Korelya Capital and TransferWise's co-founder Taavet Hinrikus joined Didi Chuxing and a number of Taxify's other existing shareholders in the round that brings Taxify's valuation to US$1 billion. Daimler will also join Taxify's board. The transaction represents a revaluation uplift of US$13.30 million (or 350%) in the fair value of TMT's investment in Taxify, compared to the previous reported amount as of 31 December 2017.

 

Pipedrive

TMT has sold a small holding in Pipedrive, a leading sales CRM (Customer Relationship Management) software provider (www.pipedrive.com), for a total consideration of US$2.0 million. The transaction represents a revaluation uplift of US$3.14 million in the fair value of TMT's residual investment in Pipedrive, compared to the previous reported amount as of 31 December 2017. 

 

Scentbird

Scentbird, a subscription-based service for luxury fragrances and other beauty products (www.scentbird.com), has recently announced that it has completed a further funding round to raise US$18.6 million from a group of investors led by Goodwater Capital, the consumer technology investment firm, and joined by Y Combinator, Rainfall Ventures, FundersClub, Soma Capital, Scrum Ventures, ERA, and others. The transaction represented a reduction of US$3.61 million in the fair value of TMT's investment in Scentbird, compared to the previous reported amount as of 31 December 2017.

 

 

Alexander Selegenev, Executive Director of TMT, commented:

 

"We are delighted with the continuing trend of positive revaluations in our portfolio, especially from Taxify, which has now become the first "unicorn" in our portfolio, and for which we previously announced an upward revaluation less than a year ago. This is an enormous achievement for Taxify, which was co-founded by then 19-year-old Markus Villig, who borrowed his college money from his parents to launch the company in Estonia in 2013. Today, Taxify is one of the fastest-growing ride-hailing companies in the world with over 10 million passengers and 500,000 drivers in more than 25 countries.

 

Notwithstanding that Scentbird's latest funding round valuation represents a discount to the valuation achieved by TMT at the time of a partial sale of its investment in Q4 2017, we are pleased to see that Scentbird's superb growth to date has allowed it to raise a significant round of $18.6m from a group of prestigious and experienced investors. This will enable Scentbird to further increase market penetration and accelerate growth. According to Forbes Magazine, Scentbird's capital raise was "one of the largest Series A funding rounds secured by a direct-to-consumer brand led by a female CEO".

 

TMT shares now trade at a discount to the Company's estimated NAV."

 

This announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information contact:

 

TMT Investments PLC

Alexander Selegenev

Executive Director

www.tmtinvestments.com

 

+44 1534 281 843

alexander.selegenev@tmtinvestments.com

 

Smith & Williamson Corporate Finance Ltd

Nominated Adviser

Russell Cook

David Jones

Ben Jeynes

 

+44 (0)20 7131 4000

Hybridan LLP

Broker

Claire Louise Noyce

 

+44 20 3764 2341

Kinlan Communications

David Hothersall

 

+44 20 7638 3435

davidh@kinlan.net

 

 

About TMT Investments PLC

 

TMT Investments PLC invests in high-growth technology companies across a number of core specialist sectors and has a significant number of Silicon Valley investments in its portfolio. Founded in 2010, TMT has invested in over 40 companies to date and has latest audited net assets of US$67m. The Company's objective is to generate an attractive rate of return for shareholders, predominantly through capital appreciation. The company is traded on the AIM market of the London Stock Exchange. www.tmtinvestments.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRALMMTMBITTTP
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSLaunch of Share Buyback Programme
19th May 202612:14 pmRNSResult of Annual General Meeting
24th Mar 20267:00 amRNSFinal Results and Notice of AGM
19th Mar 20267:00 amRNSNotice of Final Results
24th Dec 20257:00 amRNSCompletion of Share Buyback Programme
23rd Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20258:16 amRNSPDMR Dealings
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20256:26 pmRNSPDMR Dealings
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20258:04 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSLaunch of Share Buyback Programme
21st Oct 202510:31 amRNSHoldings in Company
27th Aug 20255:00 pmRNSPDMR Dealings
12th Aug 20257:00 amRNSHalf-year Report
18th Jul 20251:45 pmRNSNotice of Interim Results
9th Jul 20257:00 amRNSPDMR Dealing
16th Jun 202511:54 amRNSPortfolio Update
20th May 20254:55 pmRNSResult of AGM
17th Apr 20252:45 pmRNSDirector Dealing
10th Apr 202512:00 pmRNSDirector Dealing
25th Mar 20257:00 amRNSFinal Results and Notice of AGM
20th Feb 20256:02 pmRNSDirector Dealing
10th Dec 20247:00 amRNSDirector Dealing
15th Aug 20247:00 amRNSHalf-year Report
6th Jun 20247:00 amRNSPortfolio Update
28th May 20245:10 pmRNSResult of AGM
9th May 202410:03 amRNSDirector Dealing
19th Mar 20247:00 amRNSFinal Results and Notice of AGM
28th Feb 20241:26 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.